RX-3117, an oral hypomethylating agent to treat advanced solid tumors (st): Interim results from an ongoing phase 2a study in advanced urothelial cancer

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Annals of oncology 2017-09, Vol.28, p.v308-v308
Hauptverfasser:	Maia, M.C., Pal, S.K., Tagawa, S.T., Chung, V., Picus, J., Gupta, S., Poore, J., Peterson, C., Benaim, E.
Format:	Artikel
Sprache:	eng
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

container_end_page	v308
container_issue
container_start_page	v308
container_title	Annals of oncology
container_volume	28
creator	Maia, M.C. Pal, S.K. Tagawa, S.T. Chung, V. Picus, J. Gupta, S. Poore, J. Peterson, C. Benaim, E.
description
doi_str_mv	10.1093/annonc/mdx371.027
format	Article
fullrecord	<record><control><sourceid>elsevier_cross</sourceid><recordid>TN_cdi_crossref_primary_10_1093_annonc_mdx371_027</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S0923753420381461</els_id><sourcerecordid>S0923753420381461</sourcerecordid><originalsourceid>FETCH-LOGICAL-c1377-2e138c45adbcd9704add3ed4b04fe69e6b1965453c5b8625178697a34037daef3</originalsourceid><addsrcrecordid>eNp9kM1KAzEUhYMoWKsP4C5LBccmk5lJoysp_hQKgii4C2lyp43MJCVJi_MmPq4zVnDn6sKF83HOh9A5JdeUCDZRznmnJ635ZJxek5wfoBEtK5FNSUEP0YiInGW8ZMUxOonxgxBSiVyM0NfLe8Yo5VdYOeyDavC62_gW0rprVLJuhdUKXMLJ4xRAJazMTjkNBkffWIPTtvUh4ouYLm_w3CUItsUB4rZJEdfBtz9ct_IDarNWEXCucExb02Hr_mjb4NMaGtsX0MMnnKKjWjURzn7vGL093L_OnrLF8-N8drfINGWcZzlQNtVFqcxSG8FJoYxhYIolKWqoBFRLKqqyKJkul9MqLymfVoIrVhDGjYKajRHdc3XwMQao5aafoEInKZGDWrlXK_dqZa-2z9zuM9AX21kIMmoLww4bQCdpvP0n_Q1XfoYM</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype></control><display><type>article</type><title>RX-3117, an oral hypomethylating agent to treat advanced solid tumors (st): Interim results from an ongoing phase 2a study in advanced urothelial cancer</title><source>EZB-FREE-00999 freely available EZB journals</source><source>Alma/SFX Local Collection</source><creator>Maia, M.C. ; Pal, S.K. ; Tagawa, S.T. ; Chung, V. ; Picus, J. ; Gupta, S. ; Poore, J. ; Peterson, C. ; Benaim, E.</creator><creatorcontrib>Maia, M.C. ; Pal, S.K. ; Tagawa, S.T. ; Chung, V. ; Picus, J. ; Gupta, S. ; Poore, J. ; Peterson, C. ; Benaim, E.</creatorcontrib><identifier>ISSN: 0923-7534</identifier><identifier>EISSN: 1569-8041</identifier><identifier>DOI: 10.1093/annonc/mdx371.027</identifier><language>eng</language><publisher>Elsevier Ltd</publisher><ispartof>Annals of oncology, 2017-09, Vol.28, p.v308-v308</ispartof><rights>2017 European Society for Medical Oncology</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,776,780,27901,27902</link.rule.ids></links><search><creatorcontrib>Maia, M.C.</creatorcontrib><creatorcontrib>Pal, S.K.</creatorcontrib><creatorcontrib>Tagawa, S.T.</creatorcontrib><creatorcontrib>Chung, V.</creatorcontrib><creatorcontrib>Picus, J.</creatorcontrib><creatorcontrib>Gupta, S.</creatorcontrib><creatorcontrib>Poore, J.</creatorcontrib><creatorcontrib>Peterson, C.</creatorcontrib><creatorcontrib>Benaim, E.</creatorcontrib><title>RX-3117, an oral hypomethylating agent to treat advanced solid tumors (st): Interim results from an ongoing phase 2a study in advanced urothelial cancer</title><title>Annals of oncology</title><issn>0923-7534</issn><issn>1569-8041</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2017</creationdate><recordtype>article</recordtype><recordid>eNp9kM1KAzEUhYMoWKsP4C5LBccmk5lJoysp_hQKgii4C2lyp43MJCVJi_MmPq4zVnDn6sKF83HOh9A5JdeUCDZRznmnJ635ZJxek5wfoBEtK5FNSUEP0YiInGW8ZMUxOonxgxBSiVyM0NfLe8Yo5VdYOeyDavC62_gW0rprVLJuhdUKXMLJ4xRAJazMTjkNBkffWIPTtvUh4ouYLm_w3CUItsUB4rZJEdfBtz9ct_IDarNWEXCucExb02Hr_mjb4NMaGtsX0MMnnKKjWjURzn7vGL093L_OnrLF8-N8drfINGWcZzlQNtVFqcxSG8FJoYxhYIolKWqoBFRLKqqyKJkul9MqLymfVoIrVhDGjYKajRHdc3XwMQao5aafoEInKZGDWrlXK_dqZa-2z9zuM9AX21kIMmoLww4bQCdpvP0n_Q1XfoYM</recordid><startdate>201709</startdate><enddate>201709</enddate><creator>Maia, M.C.</creator><creator>Pal, S.K.</creator><creator>Tagawa, S.T.</creator><creator>Chung, V.</creator><creator>Picus, J.</creator><creator>Gupta, S.</creator><creator>Poore, J.</creator><creator>Peterson, C.</creator><creator>Benaim, E.</creator><general>Elsevier Ltd</general><scope>6I.</scope><scope>AAFTH</scope><scope>AAYXX</scope><scope>CITATION</scope></search><sort><creationdate>201709</creationdate><title>RX-3117, an oral hypomethylating agent to treat advanced solid tumors (st): Interim results from an ongoing phase 2a study in advanced urothelial cancer</title><author>Maia, M.C. ; Pal, S.K. ; Tagawa, S.T. ; Chung, V. ; Picus, J. ; Gupta, S. ; Poore, J. ; Peterson, C. ; Benaim, E.</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c1377-2e138c45adbcd9704add3ed4b04fe69e6b1965453c5b8625178697a34037daef3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2017</creationdate><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Maia, M.C.</creatorcontrib><creatorcontrib>Pal, S.K.</creatorcontrib><creatorcontrib>Tagawa, S.T.</creatorcontrib><creatorcontrib>Chung, V.</creatorcontrib><creatorcontrib>Picus, J.</creatorcontrib><creatorcontrib>Gupta, S.</creatorcontrib><creatorcontrib>Poore, J.</creatorcontrib><creatorcontrib>Peterson, C.</creatorcontrib><creatorcontrib>Benaim, E.</creatorcontrib><collection>ScienceDirect Open Access Titles</collection><collection>Elsevier:ScienceDirect:Open Access</collection><collection>CrossRef</collection><jtitle>Annals of oncology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Maia, M.C.</au><au>Pal, S.K.</au><au>Tagawa, S.T.</au><au>Chung, V.</au><au>Picus, J.</au><au>Gupta, S.</au><au>Poore, J.</au><au>Peterson, C.</au><au>Benaim, E.</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>RX-3117, an oral hypomethylating agent to treat advanced solid tumors (st): Interim results from an ongoing phase 2a study in advanced urothelial cancer</atitle><jtitle>Annals of oncology</jtitle><date>2017-09</date><risdate>2017</risdate><volume>28</volume><spage>v308</spage><epage>v308</epage><pages>v308-v308</pages><issn>0923-7534</issn><eissn>1569-8041</eissn><pub>Elsevier Ltd</pub><doi>10.1093/annonc/mdx371.027</doi><oa>free_for_read</oa></addata></record>
fulltext	fulltext
identifier	ISSN: 0923-7534
ispartof	Annals of oncology, 2017-09, Vol.28, p.v308-v308
issn	0923-7534 1569-8041
language	eng
recordid	cdi_crossref_primary_10_1093_annonc_mdx371_027
source	EZB-FREE-00999 freely available EZB journals; Alma/SFX Local Collection
title	RX-3117, an oral hypomethylating agent to treat advanced solid tumors (st): Interim results from an ongoing phase 2a study in advanced urothelial cancer
url	https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-08T02%3A43%3A25IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-elsevier_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=RX-3117,%20an%20oral%20hypomethylating%20agent%20to%20treat%20advanced%20solid%20tumors%20(st):%20Interim%20results%20from%20an%20ongoing%20phase%202a%20study%20in%20advanced%20urothelial%20cancer&rft.jtitle=Annals%20of%20oncology&rft.au=Maia,%20M.C.&rft.date=2017-09&rft.volume=28&rft.spage=v308&rft.epage=v308&rft.pages=v308-v308&rft.issn=0923-7534&rft.eissn=1569-8041&rft_id=info:doi/10.1093/annonc/mdx371.027&rft_dat=%3Celsevier_cross%3ES0923753420381461%3C/elsevier_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/&rft_els_id=S0923753420381461&rfr_iscdi=true